O'Shaughnessy Asset Management, LLC Sarepta Therapeutics, Inc. Transaction History
O'Shaughnessy Asset Management, LLC
- $11.5 Billion
- Q4 2024
A detailed history of O'Shaughnessy Asset Management, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 2,363 shares of SRPT stock, worth $173,940. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,363
Previous 3,839
38.45%
Holding current value
$173,940
Previous $479,000
40.08%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding SRPT
# of Institutions
534Shares Held
85.3MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$760 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$669 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$640 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$319 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$300 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $6.45B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...